Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treatment using humanized anti-CD11a antibodies

Method of treatment using humanized anti-CD11a antibodies

US Patent 6703018 · Granted Mar 9, 2004

Estimated economic value: $378,616,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19/anti-CD38 common light chain bispecific antibodies2025
Binding molecules with modified J-chain2025
CD25 antibodies2025
Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using 2025
Anti-TREM2 antibodies and related methods2025
Anti-MARCO antibodies and uses thereof2025
Single-chain TNF Receptor 2 agonist fusion proteins2025
Anti-PVRIG antibodies and methods of use2025
Nucleic acids encoding, and methods of producing, antibodies that bind human che2025
Chimeric antigen receptor effector cell switches with humanized targeting moieti2025
Humanized anti-CD3 antibodies, conjugates and uses thereof2025
Anti-CD33 antibodies and methods of use thereof2025